Clinical Trial Update: 2013/2017 H7N9 Prime-Boost Interval [Phase 2]

View source ↗

Summary

Phase 2 trial update on H7N9 prime-boost interval; completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza
• Influenza Immunisation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Avian Influenza, Influenza Immunisation | Phase 2 | Status: COMPLETED | Results posted: 2021-08-02